Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» NeuroDerm shares up 65 percent on mid-stage results for Parkinson's disease drugs
NeuroDerm shares up 65 percent on mid-stage results for Parkinson's disease drugs
NeuroDerm shares up 65 percent on mid-stage results for Parkinson's disease drugs
Submitted by
admin
on December 30, 2014 - 11:50am
Source:
First Word Pharma
News Tags:
NeuroDerm
Parkinson's Disease
ND0612H
ND0612L
Headline:
NeuroDerm shares up 65 percent on mid-stage results for Parkinson's disease drugs
Do Not Allow Advertisers to Use My Personal information